Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-005730

EVP and Chief Medical Officer gave up 1,624 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · EVP and Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-01-30 Shares withheld for taxes : show line 1 in the form −1,624 $53.23 $86,446 24,615 D
Loading xslF345X03/doc4.xml…